Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Author: Root Adam R.   Cao Wei   Li Bilian   LaPan Peter   Meade Caryl   Sanford Jocelyn   Jin Macy   O’Sullivan Cliona   Cummins Emma   Lambert Matthew   Sheehan Alfredo D.   Ma Weijun   Gatto Scott   Kerns Kelvin   Lam Khetemenee   D’Antona Aaron M.   Zhu Lily   Brady William A.   Benard Susan   King Amy   He Tao   Racie Lisa   Arai Maya   Barrett Dianah   Stochaj Wayne   LaVallie Edward R.   Apgar James R.   Svenson Kristine   Mosyak Lidia   Yang Yinhua   Chichili Gurunadh R.   Liu Liqin   Li Hua   Burke Steve   Johnson Syd   Alderson Ralph   Finlay William J. J.   Lin Laura   Olland Stéphane   Somers William   Bonvini Ezio   Gerber Hans-Peter   May Chad   Moore Paul A.   Tchistiakova Lioudmila   Bloom Laird  

Publisher: MDPI

E-ISSN: 2073-4468|5|1|6-6

ISSN: 2073-4468

Source: Antibodies, Vol.5, Iss.1, 2016-03, pp. : 6-6

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract